Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Poseida makes case for safety of Roche-partnered nonviral CAR-T
Poseida is showcasing data for a Roche-partnered candidate that uses a nonviral approach and could therefore offer a better CAR-T safety profile.
Gabrielle Masson
Dec 10, 2023 12:00pm
Roche’s breast cancer drug hits primary endpoint in phase 3
Dec 5, 2023 4:12am
Genentech MS drug on partial US hold on liver enzyme elevations
Dec 4, 2023 12:54pm
UPDATE: Roche muscles in on obesity market with $2.7B Carmot buy
Dec 4, 2023 5:26am
Phenomic inks 2nd deal in 2 days, Shape adds to Roche pact
Nov 30, 2023 10:14am
Roche grows hepatitis diagnostics roster with new immunoassays
Nov 27, 2023 10:26am
